Scientists discover the cause of Congenital Hyperinsulinism
A research team at the University of Exeter have found that the unexplored genomic control regions yield the key to finding causes of Congenital Hyperinsulinism.
List view / Grid view
A research team at the University of Exeter have found that the unexplored genomic control regions yield the key to finding causes of Congenital Hyperinsulinism.
A UNIGE team reveals that a drug used against herpes can fight a bacterium that is resistant to most antibiotics by weakening its defence mechanisms.
UCL researchers have developed a possible new treatment for neurological and psychiatric diseases, that works by reducing the excitability of overactive brain cells.
US scientists have found strong evidence for testing VCU-manufactured drugs in liver cancer.
Using DNA barcoding to track cancer cells through time, scientists have shown that the cells have diverse abilities to escape the immune system.
Researchers show how monkeypox mutations cause virus to replicate, spread faster.
UPF and John Hopkins scientists have discovered how cancer cells exposed to high viscosity environments change their movements to improve their invasiveness and favour metastases.
Scientists have generated polygenic risk scores for developing paediatric steroid sensitive nephrotic syndrome (pSSNS), a kidney disease in children.
Spanish researchers have discovered that vitamin C may hold the key to improving the efficacy of dendritic cell-derived anticancer therapies.
The NPGPx protein is active in foetuses, but largely dormant and absent in diabetic adults.
Researchers have streamlined the traditionally slow process of enzyme engineering. This work might help researchers tailor the suitability of enzymes for custom purposes.
The College of American Pathologists has given accreditation to Altasciences’ clinical site in Los Angeles, California.
MIT researchers have developed a technique that could help the production of monoclonal antibodies and other useful proteins.
Researchers from the University of California have developed the first pre-clinical model of appendiceal cancer, containing all elements of the tumour.
The researchers used a zebrafish model to test mutations in Mycn, a gene which causes Feingold syndrome.